BRPI0913184A2 - análogo de albumina totalmente sintético, revestimento hematicamente compatível para superfícies que entram em contato com sangue, dispositivo médico, utilização de um análogo de albumina totalmente sintético. - Google Patents

análogo de albumina totalmente sintético, revestimento hematicamente compatível para superfícies que entram em contato com sangue, dispositivo médico, utilização de um análogo de albumina totalmente sintético.

Info

Publication number
BRPI0913184A2
BRPI0913184A2 BRPI0913184A BRPI0913184A BRPI0913184A2 BR PI0913184 A2 BRPI0913184 A2 BR PI0913184A2 BR PI0913184 A BRPI0913184 A BR PI0913184A BR PI0913184 A BRPI0913184 A BR PI0913184A BR PI0913184 A2 BRPI0913184 A2 BR PI0913184A2
Authority
BR
Brazil
Prior art keywords
fully synthetic
synthetic albumin
hematically
medical device
contacting surfaces
Prior art date
Application number
BRPI0913184A
Other languages
English (en)
Inventor
Hans-Dieter Lehmann
Original Assignee
Ls Medcap Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ls Medcap Gmbh filed Critical Ls Medcap Gmbh
Publication of BRPI0913184A2 publication Critical patent/BRPI0913184A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
BRPI0913184A 2008-05-30 2009-05-22 análogo de albumina totalmente sintético, revestimento hematicamente compatível para superfícies que entram em contato com sangue, dispositivo médico, utilização de um análogo de albumina totalmente sintético. BRPI0913184A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008027133A DE102008027133A1 (de) 2008-05-30 2008-05-30 Vollsynthetisches Albumin-Analogon
PCT/EP2009/003651 WO2009146803A1 (de) 2008-05-30 2009-05-22 Vollsynthetisches albumin-analogon

Publications (1)

Publication Number Publication Date
BRPI0913184A2 true BRPI0913184A2 (pt) 2016-01-12

Family

ID=41040475

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913184A BRPI0913184A2 (pt) 2008-05-30 2009-05-22 análogo de albumina totalmente sintético, revestimento hematicamente compatível para superfícies que entram em contato com sangue, dispositivo médico, utilização de um análogo de albumina totalmente sintético.

Country Status (7)

Country Link
US (1) US8309520B2 (pt)
EP (1) EP2285414B1 (pt)
CN (1) CN102046206A (pt)
BR (1) BRPI0913184A2 (pt)
DE (1) DE102008027133A1 (pt)
ES (1) ES2406305T3 (pt)
WO (1) WO2009146803A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008027133A1 (de) * 2008-05-30 2009-12-03 Ls Medcap Gmbh Vollsynthetisches Albumin-Analogon

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4022695A1 (de) * 1990-07-17 1992-01-23 Korea Inst Sci & Tech Sulfonierte, polyethylenoxidsubstituierte polymere mit verbesserter blut-vertraeglichkeit
WO1993010824A1 (fr) * 1991-12-04 1993-06-10 Guerbet S.A. Nouveau compose macromoleculaire polyamine iode, son procede de preparation et son utilisation comme agent de contraste
US5871713A (en) 1991-12-04 1999-02-16 Guerbet S.A. Macromolecular polyamine iodine-containing compound, process for its preparation and its use as a contrast agent
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6465525B1 (en) * 1998-03-18 2002-10-15 Surmodics, Inc. Latent reactive blood compatible agents
DE19818614A1 (de) 1998-04-20 1999-10-21 Basf Ag Neue substituierte Amide, deren Herstellung und Anwendung
DE10031740A1 (de) 2000-06-29 2002-02-14 Sanguibio Tech Ag Künstliche Sauerstoffträger aus vernetztem modifizierten Human- oder Schweinehämoglobin mit verbesserten Eigenschaften, Verfahren zu ihrer technisch einfachen Herstellung aus gereinigtem Material in hohen Ausbeuten, sowie deren Verwendung
DE10221055B4 (de) * 2002-05-10 2007-10-25 Hemoteq Ag Verbindungen zur hämokompatiblen Beschichtung von Oberflächen, Verfahren zu deren Herstellung und deren Verwendung
PT1501566E (pt) 2002-05-09 2008-11-13 Hemoteq Ag Produtos médicos que compreendem um revestimento hemocompatível, produção e utilização do mesmo
WO2004037310A2 (en) * 2002-10-21 2004-05-06 Allvivo, Inc. Surface coating comprising bioactive compound
JP2006521355A (ja) * 2003-03-17 2006-09-21 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア・センター・フオー・テクノロジー・トランスフアー 表面的に両親媒性のポリマー及びオリゴマーならびにそれらの使用
DE10329296B4 (de) * 2003-06-24 2007-07-12 Leibniz-Institut Für Polymerforschung Dresden E.V. Beschichtungssystem für Biomaterialien
DE10330900B4 (de) * 2003-07-01 2006-09-14 Leibniz-Institut Für Polymerforschung Dresden E.V. Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt
US20060015057A1 (en) * 2004-07-15 2006-01-19 Ho Chih-Hu Coating for arterial-venous blood tubing set for hemodialysis system
US20070005064A1 (en) 2005-06-27 2007-01-04 Sdgi Holdings Intervertebral prosthetic device for spinal stabilization and method of implanting same
DE102005040211B4 (de) 2005-08-16 2010-02-11 Maquet Cardiopulmonary Ag Verwendung von nichtionischen Estern in einer Beschichtung für mit Blut in Kontakt kommende Oberflächen und medizinische Vorrichtung
NZ569756A (en) * 2005-12-12 2011-07-29 Allaccem Inc Methods and systems for preparing antimicrobial films and coatings utilising polycyclic bridged ammonium salts
DE102008027133A1 (de) * 2008-05-30 2009-12-03 Ls Medcap Gmbh Vollsynthetisches Albumin-Analogon

Also Published As

Publication number Publication date
CN102046206A (zh) 2011-05-04
DE102008027133A1 (de) 2009-12-03
US20110117139A1 (en) 2011-05-19
ES2406305T3 (es) 2013-06-06
WO2009146803A1 (de) 2009-12-10
EP2285414B1 (de) 2013-04-10
US8309520B2 (en) 2012-11-13
EP2285414A1 (de) 2011-02-23

Similar Documents

Publication Publication Date Title
BRPI0922699A2 (pt) sistemas e métodos para a aplicação de um revestimento antimicrobiano em um dispositivo médico
DK2073860T3 (da) Lægemiddelfrigivende coatinger til medicinske indretninger
BRPI1016210A2 (pt) uso de siloxanos organomodificados, ramificados na parte do silicone para a produção de composições cosméticas ou farmacêuticas
BRPI1016234A2 (pt) dispositivo aplicador para uso médico e/ou cosmético.
BRPI0915302A2 (pt) artigo absorvente que compreende um campo de design
BRPI0922066A2 (pt) processos para a fabricação de metilmercaptopropionaldeido e da metionina ou do hidroxianalogo da metionina, metilmercaptopropinaldeido,metionina ou hidroxianalogo da metionina, e, utilização da metionina ou do hidroxianalogo da metionina.
BRPI0921997A2 (pt) dispositivo para medição do componente de sangue.
DK3311775T3 (da) Fastholdelsesmekanisme til hjerteklapproteser
BRPI0909625A2 (pt) agonista seletivo do receptor s1p1 para o uso como um medicamento, uso do mesmo e kit que contém diferentes unidades de medicação de um agonista seletivo do receptor s1p1
BR112012005853A2 (pt) aplicador automático para preparações farmacêuticas líquidas, particularmente para insulina
DK2034903T3 (da) Applikator til kirurgisk klæbemiddel
BRPI0812372A2 (pt) Válvula cardíaca protética.
BRPI0817437A2 (pt) Implante cirúrgico com um recurso antirretrocesso
BRPI0914802A2 (pt) Composto, pró-droga, medicamento, uso do composto ou uma pró-droga de mesmo.
DK2111212T3 (da) Medicindispenseringssystem og -fremgangsmåde
BRPI0920392A2 (pt) reservatório de sangue
SM200800007A (it) Apparato medicale di iniezione
FR2933724B1 (fr) Unite de soins medicaux autonome
BRPI0818384A2 (pt) dispositivo de seringa que compreende um corpo de seringa e uma luva de sustentação
BRPI0909416A2 (pt) Utensílios médicos com revestimentos hidrofílicos
BRPI0819257A2 (pt) monitor de pressão sanguínea
BRPI0906578A2 (pt) Adesivos médicos para a cirurgia
DK2265296T3 (da) Medicinske apparater med hydrofile belægninger
BRPI0907191A2 (pt) Solução, método para preparar uma solução, método para aumentar a penetração cutânea de imiquimod ou um análogo do mesmo
BRPI0822206A2 (pt) Formulação líquida para deferiprona com um sabor agradável.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: C07K 14/765 (2006.01), A61K 47/60 (2017.01), A61L